RESEARCH TRIANGLE PARK, N.C., Feb. 04, 2019 — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate (STS) to be administered by infusion) for the prevention of ototoxicity induced by cisplatin chemotherapy in pediatric patients with solid tumors, announced a $12.5 million […]
This author has yet to write their bio.Meanwhile lets just say that we are proud admin contributed a whooping 3 entries.
Entries by admin
RESEARCH TRIANGLE PARK, NORTH CAROLINA — (Marketwire) – April 28, 2014 – Adherex Technologies, Inc. (TSX:AHX, OTC: ADHXF) today announced the appointment of Dr. Khalid Islam and Adrian Haigh to the Company’s Board of Directors, effective immediately. With these additions, the Adherex Board is now comprised of five directors, four of whom are independent. “We welcome […]
– COG STUDY ACCL0431 oral presentation for hearing protection in rare childhood cancers – SIOPEL 6 poster presentation for hearing protection in standard risk hepatoblastoma RESEARCH TRIANGLE PARK, NORTH CAROLINA–(Marketwire) – April 22, 2014) – Adherex Technologies, Inc. (TSX:AHX, OTC: ADHXF) today announced that both of the Phase III studies being conducted on Sodium Thiosulfate (STS) […]